Literature DB >> 22709945

Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome.

Bianca De Filippis1, Laura Ricceri, Andrea Fuso, Giovanni Laviola.   

Abstract

Rett syndrome (RTT) is a pervasive neurodevelopmental disorder, primarily affecting girls. RTT causes a wide variety of debilitating symptoms and no cure currently exists. Mouse models bearing mutations in the Mecp2 gene recapitulate most physiological and behavioural RTT-related abnormalities. Stimulating neonatal environments (e.g. brief maternal separations or maternal low-dose corticosterone supplementation) reduce stress and fear responses at adulthood. The present study investigated whether impacting early in development the hypothalamic-pituitary-adrenal axis, by exposing Mecp2-308 mutant pups to a low dose of corticosterone (50 µg/ml, during the 1st week of life) may contrast RTT-related abnormalities in neuroendocrine regulation and behavioural adaptation at adulthood. In line with previous reports, when fully symptomatic, MeCP2-308 mice showed a reduction in the regular nocturnal hyperactivity in the home-cage and increased anxiety-like behaviours and plasma corticosterone (CORT) levels in response to restraint stress. An abnormal elevation in mRNA levels of mineralocorticoid receptors (MR) and BDNF gene was also evident in the hippocampus of fully symptomatic mutant mice. Neonatal CORT modulated MR gene expression and behavioural reactivity towards a novel object, also restoring wt-like levels of locomotor/exploratory behaviour in mutant mice. Enhanced sensitivity to the neonatal treatment (in terms of increase in GR and MR mRNA levels), was also evident in the hippocampus of MeCP2-308 mice compared to wt littermates. Present results corroborate the hypothesis that targeting the glucocorticoid system may prove valid in contrasting at least some of the RTT-related symptoms and provide evidence that pharmacological interventions during critical early time windows can persistently improve the behavioural phenotype of RTT mice. Current data also support the emerging role played by Mecp2 in mediating the epigenetic programming induced by early life events and indicate that, in the absence of functional MeCP2, programming of the central nervous system in response to early environmental stimuli is abnormally regulated. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22709945     DOI: 10.1016/j.neuropharm.2012.05.048

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

1.  Differential Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA Isoforms in Brain Cells from Mecp2(308/y) Mouse Model.

Authors:  Audrey Rousseaud; Chloé Delépine; Juliette Nectoux; Pierre Billuart; Thierry Bienvenu
Journal:  J Mol Neurosci       Date:  2015-01-30       Impact factor: 3.444

Review 2.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

Review 3.  Glucocorticoids and fetal programming part 2: Mechanisms.

Authors:  Vasilis G Moisiadis; Stephen G Matthews
Journal:  Nat Rev Endocrinol       Date:  2014-05-27       Impact factor: 43.330

4.  MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism.

Authors:  Ki Chan Kim; Chang Soon Choi; Ji-Woon Kim; Seol-Heui Han; Jae Hoon Cheong; Jong Hoon Ryu; Chan Young Shin
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

Review 5.  BDNF deregulation in Rett syndrome.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  Neuropharmacology       Date:  2013-04-15       Impact factor: 5.250

6.  Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome.

Authors:  Bianca De Filippis; Valentina Chiodi; Walter Adriani; Enza Lacivita; Cinzia Mallozzi; Marcello Leopoldo; Maria Rosaria Domenici; Andrea Fuso; Giovanni Laviola
Journal:  Front Behav Neurosci       Date:  2015-04-14       Impact factor: 3.558

Review 7.  Treating Rett syndrome: from mouse models to human therapies.

Authors:  Neeti Vashi; Monica J Justice
Journal:  Mamm Genome       Date:  2019-02-28       Impact factor: 2.957

Review 8.  Stress-Sensitive Protein Rac1 and Its Involvement in Neurodevelopmental Disorders.

Authors:  Xiaohui Wang; Dongbin Liu; Fangzhen Wei; Yue Li; Xuefeng Wang; Linjie Li; Guan Wang; Shuli Zhang; Lei Zhang
Journal:  Neural Plast       Date:  2020-11-24       Impact factor: 3.599

9.  MeCP2 haplodeficiency and early-life stress interaction on anxiety-like behavior in adolescent female mice.

Authors:  María Abellán-Álvaro; Oliver Stork; Carmen Agustín-Pavón; Mónica Santos
Journal:  J Neurodev Disord       Date:  2021-12-11       Impact factor: 4.025

10.  Long-term home cage activity scans reveal lowered exploratory behaviour in symptomatic female Rett mice.

Authors:  Lianne Robinson; Andrea Plano; Stuart Cobb; Gernot Riedel
Journal:  Behav Brain Res       Date:  2013-05-01       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.